Matrigel dome assay and drug screening of colorectal cancer organoids
24 March 2024

Automation platforms like the BAB400 enable the efficient handling and treatment of organoids, improving reproducibility and scalability. By automating tasks such as seeding, media exchange, and drug treatment, these platforms streamline workflows and allow for better focus on model development. In this application note, Molecular Devices, using CRC organoids, demonstrates BAB400 automation for uniform distribution and drug response assessments, showing cytotoxic and cytostatic effects of anti-cancer compounds.